Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92


Comparative profiling of miRNA expression of lung adenocarcinoma cells in two-dimensional and three-dimensional cultures.

Li C, Nguyen HT, Zhuang Y, Lin Z, Flemington EK, Zhuo Y, Kantrow SP, Morris GF, Sullivan DE, Shan B.

Gene. 2012 Dec 15;511(2):143-50. doi: 10.1016/j.gene.2012.09.093. Epub 2012 Oct 2.


The microRNA expression associated with morphogenesis of breast cancer cells in three-dimensional organotypic culture.

Nguyen HT, Li C, Lin Z, Zhuang Y, Flemington EK, Burow ME, Lin YI, Shan B.

Oncol Rep. 2012 Jul;28(1):117-126. doi: 10.3892/or.2012.1764. Epub 2012 Apr 19.


Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.

Pak MG, Lee CH, Lee WJ, Shin DH, Roh MS.

Diagn Pathol. 2015 Jul 12;10:99. doi: 10.1186/s13000-015-0339-4.


MiR-134/487b/655 cluster regulates TGF-β-induced epithelial-mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells.

Kitamura K, Seike M, Okano T, Matsuda K, Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K, Gemma A.

Mol Cancer Ther. 2014 Feb;13(2):444-53. doi: 10.1158/1535-7163.MCT-13-0448. Epub 2013 Nov 20.


Lung adenocarcinoma subtypes definable by lung development-related miRNA expression profiles in association with clinicopathologic features.

Arima C, Kajino T, Tamada Y, Imoto S, Shimada Y, Nakatochi M, Suzuki M, Isomura H, Yatabe Y, Yamaguchi T, Yanagisawa K, Miyano S, Takahashi T.

Carcinogenesis. 2014 Oct;35(10):2224-31. doi: 10.1093/carcin/bgu127. Epub 2014 Jun 5.


MicroRNA-29b is involved in the Src-ID1 signaling pathway and is dysregulated in human lung adenocarcinoma.

Rothschild SI, Tschan MP, Federzoni EA, Jaggi R, Fey MF, Gugger M, Gautschi O.

Oncogene. 2012 Sep 20;31(38):4221-32. doi: 10.1038/onc.2011.578. Epub 2012 Jan 16.


MicroRNA expression profiles associated with acquired gefitinib-resistance in human lung adenocarcinoma cells.

Ge X, Zheng L, Huang M, Wang Y, Bi F.

Mol Med Rep. 2015 Jan;11(1):333-40. doi: 10.3892/mmr.2014.2757. Epub 2014 Oct 23.


Bcl-xL silencing induces alterations in hsa-miR-608 expression and subsequent cell death in A549 and SK-LU1 human lung adenocarcinoma cells.

Othman N, In LL, Harikrishna JA, Hasima N.

PLoS One. 2013 Dec 10;8(12):e81735. doi: 10.1371/journal.pone.0081735. eCollection 2013.


miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.

Miao Y, Li J, Qiu X, Li Y, Wang Z, Luan Y.

Oncol Rep. 2013 Jan;29(1):161-8. doi: 10.3892/or.2012.2095. Epub 2012 Oct 19.


Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression.

Allantaz F, Cheng DT, Bergauer T, Ravindran P, Rossier MF, Ebeling M, Badi L, Reis B, Bitter H, D'Asaro M, Chiappe A, Sridhar S, Pacheco GD, Burczynski ME, Hochstrasser D, Vonderscher J, Matthes T.

PLoS One. 2012;7(1):e29979. doi: 10.1371/journal.pone.0029979. Epub 2012 Jan 20.


An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma.

Luo Z, Zhang L, Li Z, Li X, Li G, Yu H, Jiang C, Dai Y, Guo X, Xiang J, Li G.

BMC Med Genomics. 2012 Jan 19;5:3. doi: 10.1186/1755-8794-5-3.


miRNA profiling of naïve, effector and memory CD8 T cells.

Wu H, Neilson JR, Kumar P, Manocha M, Shankar P, Sharp PA, Manjunath N.

PLoS One. 2007 Oct 10;2(10):e1020.


EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.

Chou YT, Lin HH, Lien YC, Wang YH, Hong CF, Kao YR, Lin SC, Chang YC, Lin SY, Chen SJ, Chen HC, Yeh SD, Wu CW.

Cancer Res. 2010 Nov 1;70(21):8822-31. doi: 10.1158/0008-5472.CAN-10-0638. Epub 2010 Oct 26.


MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma.

Davidson MR, Larsen JE, Yang IA, Hayward NK, Clarke BE, Duhig EE, Passmore LH, Bowman RV, Fong KM.

PLoS One. 2010 Sep 3;5(9):e12560. doi: 10.1371/journal.pone.0012560.


MicroRNA-200b reverses chemoresistance of docetaxel-resistant human lung adenocarcinoma cells by targeting E2F3.

Feng B, Wang R, Song HZ, Chen LB.

Cancer. 2012 Jul 1;118(13):3365-76. doi: 10.1002/cncr.26560. Epub 2011 Dec 2.


Tumor suppressive microRNA-133a regulates novel molecular networks in lung squamous cell carcinoma.

Moriya Y, Nohata N, Kinoshita T, Mutallip M, Okamoto T, Yoshida S, Suzuki M, Yoshino I, Seki N.

J Hum Genet. 2012 Jan;57(1):38-45. doi: 10.1038/jhg.2011.126. Epub 2011 Nov 17.


miRNA expression profiling in a human stem cell-based model as a tool for developmental neurotoxicity testing.

Pallocca G, Fabbri M, Sacco MG, Gribaldo L, Pamies D, Laurenza I, Bal-Price A.

Cell Biol Toxicol. 2013 Aug;29(4):239-57. doi: 10.1007/s10565-013-9250-5. Epub 2013 Aug 1.


Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

Markou A, Sourvinou I, Vorkas PA, Yousef GM, Lianidou E.

Lung Cancer. 2013 Sep;81(3):388-96. doi: 10.1016/j.lungcan.2013.05.007. Epub 2013 Jun 10.


MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cells.

Ho CS, Yap SH, Phuah NH, In LL, Hasima N.

Lung Cancer. 2014 Feb;83(2):154-62. doi: 10.1016/j.lungcan.2013.11.024. Epub 2013 Dec 6.


5-Fluorouracil and oxaliplatin modify the expression profiles of microRNAs in human colon cancer cells in vitro.

Zhou J, Zhou Y, Yin B, Hao W, Zhao L, Ju W, Bai C.

Oncol Rep. 2010 Jan;23(1):121-8.


Supplemental Content

Support Center